TABLE 2.
Microbiological susceptibility patterns of the Corynebacterium spp. detected. Percentage of susceptible strains
| Organism (n) | % of strains susceptible to:a |
||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| PEN | AMC | IPM | ERY | RIF | VAN | LZD | GEN | CIP | SXT | DOX | |
| C. striatum (10) | 20 | 50 | 70 | 20 | 100 | 100 | 100 | 10 | 10 | 10 | 60 |
| C. pseudodiphtheriticum (3) | 100 | 100 | 100 | 33 | 100 | 100 | 100 | 100 | 67 | 33 | 100 |
| C. amycolatum (3) | 0 | 0 | 33 | 33 | 100 | 100 | 100 | 0 | 0 | 0 | 100 |
| Corynebacterium spp. (3)b | 100 | 100 | 100 | 0 | 100 | 100 | 100 | 100 | 67 | 100 | 100 |
a
AMC, amoxicillin-clavulanic acid; CIP, ciprofloxacin; DOX, doxycycline; ERY, erythromycin; GEN, gentamicin; IPM, imipenem; LZD, linezolid; PEN, penicillin; RIF, rifampin; SXT, trimethoprim-sulfamethoxazole; VAN, vancomycin.
b
Data from one isolate each of C. tuberculostearicum, C. argentoratense, and C. accolens.